Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 15,700 shares at $135.51 ($2.1M) on 2016-08-15, disclosed to the SEC on 2016-08-24.
Open-market sale of $2.1M ALXN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $135.51 | 700 | $95K | 4.4% |
| 2 | $136.53 | 15,000 | $2.0M | 95.6% |
| Total | $136.48 avg | 15,700 | $2.1M | 100% |
| Filing → |
| ALXN | SELL | 2015-11-04 | $160K | — | Filing → |
| ALXN | SELL | 2014-11-13 | $2.9M | — | Filing → |
| ALXN | SELL | 2014-05-15 | $2.0M | — | Filing → |